NEW CRITERIA FOR THE TREATMENT OF LIPID METABOLISM DISORDERS: HIGHLIGHTS OF THE 2025 ESC/EAS RECOMMENDATIONS
In 2025 the European Society of Cardiology and the European Atherosclerosis Society updated their 2019 guidelines for the diagnosis and management of dyslipidemia, based on the latest advances in lipid-lowering therapy. Key updates include the introduction of cardiovascular risk assessment using the new SCORE2 and SCOR...